Precision painkillers that are more accurate and less harmful to the liver are set to be developed by a University of Queensland spin-off company — potentially changing the lives of millions of people.
4 November 2022University of Queensland biotech start-up, Spinifex Pharmaceuticals Pty Ltd, has secured A$6.3 million in the final tranche of an A$18.3 million series B round to fund clinical efficacy trials of its innovative neuropathic (nerve) pain therapy.
9 September 2011
